Monitoring of Venous Ulcers Using a Bioimpedance Measurement Based Method and System

ConditionVenous Ulcer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCutoSense Oy

About this trial

The purpose of this study is to investigate the functionality of a new type of wound monitoring method and measurement system for monitoring healing of venous ulcers. The system is consisted of a wound dressing with electrodes (eDressing), a bioimpedance measurement device and a mobile phone application.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age at least 18 years

The subject has a chronic lower extremity ulcer with a primary etiology of venous insufficiency. The previous venous procedure is not an obstacle to the study

Compression therapy can be implemented

The wound is not wider than 5 cm and the electrode dressing can be placed on the wound as intended. The wound should be located above the ankle, on the skin area where the electrode dressing can be placed properly.

Disqualifiers

Clinical wound infection at the time of the study

The subject has an intravenous (in Tampere: A venous operation) procedure within 2 months

Significant arterial circulatory disorder or adherence problem that prevents compression therapy (in Tampere: Contraindication for compression therapy, e.g. significant arterial circulatory disorder or severe heart failure)

Subject movement 2-3 times a week during the study to the study site is difficult to arrange (in Tampere: Subject not able to commit to study visits 2-3 times a week.)

Trial design

Design model

Single group

Treatments tested in this trial

  • WoundWatch® wound monitoring system

    Device

    eDressing will be applied along with the compression therapy and the standard absorbing dressings. The subjects will be monitored using the WoundWatch® system. The subjects will have two to three study visits per week until the venous ulcer has healed (surface area has decreased at least 90%) or up to two months.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Study subject with venous ulcerExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Wound Status Index (WSI) vs. wound surface area

Correlation analysis between the WSI and the wound surface area.

Time frame
From admission to discharge, up to 8 weeks.
2

Wound Status Index (WSI) vs. wound surface area

Bland-Altman (agreement) analysis between the WSI and the wound surface area.

Time frame
From admission to discharge, up to 8 weeks.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

CutoSense Oy

Lead sponsor

University Clinical Centre, Gdansk

Collaborator

Medical University of Gdansk

Collaborator

Tampere University Hospital

Collaborator